Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label, Flexible Dose 12-Week Clinical Trial of the Safety and Efficacy of Acamprosate in the Treatment of Pathological Gambling

NCT00571103 is registered in ClinicalTrials.gov with University of Iowa as lead sponsor.

NCT NCT00571103
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00571103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label, Flexible Dose 12-Week Clinical Trial of the Safety and Efficacy of Acamprosate in the Treatment of Pathological Gambling
Lead sponsor
University of Iowa
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2007
Completion date
July 31, 2009
Enrollment
26 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pathological gambling